Profile data is unavailable for this security.
About the company
Micro-X Limited is an Australia-based company engaged in developing and commercializing a range of products for global health and security markets, based on cold cathode, carbon nanotube (CNT) emitter technology. The electronic control of emitters with this technology enables x-ray products with significant reduction in size, weight, and power requirements, enabling mobility and ease of use in existing x-ray markets and a range of security and defense applications. Its product portfolio spans four, high margin, product applications in health and security. Its segments include Micro-X Limited Australia and Micro-X Inc United States. Its products include Mobile X-Ray Machines, Argus X-Ray Camera, Miniature Baggage Scanner, and Head CT. The Company’s commercial mobile digital radiology products are sold for diagnostic imaging in global healthcare, military, and veterinary applications, and the Argus X-ray Camera for security and defense and is also available commercially.
- Revenue in AUD (TTM)15.17m
- Net income in AUD-14.51m
- Incorporated2011
- Employees--
- LocationMicro-X LtdA14 6 MAB Eastern Promenade1284 South Road, TonsleyADELAIDE 5042AustraliaAUS
- Phone+61 87099-3966
- Websitehttps://micro-x.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Resonance Health Ltd | 5.74m | -1.09m | 26.81m | 18.00 | -- | 2.85 | -- | 4.67 | -0.0025 | -0.0025 | 0.013 | 0.0211 | 0.5077 | -- | 4.93 | -- | -9.61 | -1.60 | -10.51 | -1.71 | -- | -- | -18.93 | -4.00 | -- | -- | 0.0316 | -- | 17.75 | 9.15 | 31.65 | -- | -3.06 | -- |
| Respiri Ltd | 794.32k | -6.39m | 30.96m | 2.00 | -- | 8.12 | -- | 38.97 | -0.0074 | -0.0074 | 0.0009 | 0.0033 | 0.1676 | 0.0118 | 2.79 | -- | -134.72 | -179.16 | -219.11 | -301.22 | 97.01 | -- | -803.86 | -640.45 | 1.09 | -78.80 | 0.032 | -- | -15.01 | -5.51 | 12.82 | -- | 22.51 | -- |
| Wellnex Life Ltd | 20.31m | -19.39m | 34.82m | -- | -- | 4.49 | -- | 1.71 | -0.0347 | -0.0347 | 0.0359 | 0.006 | 0.712 | 2.97 | 4.64 | -- | -67.96 | -79.54 | -133.68 | -99.28 | 12.77 | 10.10 | -95.45 | -235.50 | 0.2654 | -5.24 | 0.5516 | -- | 49.81 | 77.66 | -85.88 | -- | -- | -- |
| Curvebeam AI Ltd | 8.78m | -57.55m | 39.36m | 50.00 | -- | 1.22 | -- | 4.48 | -0.18 | -0.18 | 0.0275 | 0.1477 | 0.1347 | 0.5618 | 3.47 | -- | -88.33 | -- | -115.31 | -- | 48.78 | -- | -655.67 | -- | 1.97 | -3.10 | 0.2364 | -- | 381.77 | -- | -509.11 | -- | -- | -- |
| Universal Biosensors, Inc. | 6.81m | -6.39m | 41.73m | 97.00 | -- | 1.84 | -- | 6.13 | -0.0304 | -0.0304 | 0.0315 | 0.0762 | 0.1941 | 0.6025 | 3.61 | -- | -18.23 | -21.79 | -24.51 | -27.14 | 62.97 | 46.16 | -93.90 | -209.31 | 3.02 | -- | 0.0342 | -- | 46.58 | -37.48 | 74.90 | -- | 26.83 | -- |
| Micro-X Ltd | 15.17m | -14.51m | 48.81m | -- | -- | 4.37 | -- | 3.22 | -0.0281 | -0.0281 | 0.0294 | 0.0192 | 0.5425 | 0.8518 | 9.08 | -- | -51.87 | -43.99 | -67.43 | -59.14 | 63.58 | 65.04 | -95.61 | -130.78 | 1.28 | -56.11 | 0.3033 | -- | 14.42 | 22.25 | 37.07 | -- | 23.88 | -- |
| Nova Eye Medical Ltd | 18.70m | -14.31m | 49.20m | 130.00 | -- | 2.47 | -- | 2.63 | -0.0797 | -0.0797 | 0.102 | 0.087 | 0.6805 | 0.4822 | 8.34 | -- | -52.10 | -12.19 | -64.18 | -14.93 | 90.20 | 82.04 | -76.56 | -60.21 | 0.8106 | -- | 0.0666 | -- | 27.71 | -26.42 | -104.02 | -- | -28.45 | -- |
| Somnomed Ltd | 88.78m | -10.51m | 51.87m | 300.00 | -- | 1.13 | -- | 0.5842 | -0.0917 | -0.0926 | 0.7822 | 0.2131 | 1.38 | 7.76 | 7.52 | -- | -16.35 | -5.23 | -22.50 | -7.84 | 61.76 | 60.17 | -11.84 | -4.13 | 1.45 | -2.03 | 0.3827 | -- | 15.21 | 5.56 | -77.73 | -- | 24.17 | -- |
| Compumedics Limited | 49.62m | 1.23m | 62.01m | 135.00 | 49.16 | 3.44 | 24.20 | 1.25 | 0.0071 | 0.0071 | 0.3107 | 0.1018 | 1.24 | 2.14 | 4.43 | 367,540.80 | 3.07 | -2.91 | 6.53 | -4.63 | 53.54 | 53.44 | 2.48 | -2.90 | 0.7483 | 2.01 | 0.3385 | -- | 12.32 | 2.76 | -551.14 | -- | 16.84 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Perennial Value Management Ltd.as of 27 Feb 2024 | 60.63m | 10.43% |
| Acorn Capital Ltd.as of 17 Aug 2023 | 45.10m | 7.76% |
| Thorney Investment Group Australia Pty Ltd.as of 17 Aug 2023 | 26.28m | 4.52% |
| AustralianSuper Pty Ltd.as of 14 Dec 2022 | 23.81m | 4.10% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 15.54m | 2.67% |
| Gowing Bros. Ltd. (Investment Management)as of 17 Aug 2023 | 2.75m | 0.47% |
| DFA Australia Ltd.as of 31 May 2024 | 311.95k | 0.05% |
| Dimensional Fund Advisors LPas of 31 Jan 2024 | 261.66k | 0.05% |
